BioNTech $BNTX
BioNTech reported its results yesterday.
This company focuses and specializes in the development and research of immunotherapeutic drugs targeting the treatment of cancer and infectious diseases.
It is also known for the development and production of the COVID-19 vaccine with Pfizer.
Results for the first quarter of this year :
Revenues : EUR 1.28 billion, first...
Read more
Pfizer $PFE
Pfizer reported its quarterly results yesterday.
Sector : Pharmaceuticals.
Focus, specialization : production of drugs for humans and animals and the company also focuses on fighting various diseases such as : cancer, diabetes or Alzheimer's disease.
Products : Viagra or the vaccine against COVID-19.
Results :
Revenues : $18.3 billion
Earnings per share : $1.23
...After today's $PFE results, investors are likely to be tough on even competitor $CVS, which will report its results tomorrow before the market opens. So I expect a pullback, which I will use to increase my position. Anything around $70 is a nice price in my opinion. In fact, I don't think $CVS should come up with surprisingly good results.
I don't follow pharmaceutical companies much. Occasionally you can find nice ones that come up with a discovery (drug, method). Unfortunately, I've been burned by such startups. I don't know $CVS but I might look into a pharmaceutical company.
I would strongly consider $PFE, but I already have healthcare represented in my portfolio, so I don't want to overdo it($CVS).